NewCo

NewCo is a biotech start up with a pending launch in 1H2022. The overarching business objective of NewCo is to advance the development and application of the novel Autonomous Inducible Directed Evolution (AIDE) platform technology. AIDE allows generation of bacteria harboring tailor-made phenotypes that can address customer-specific unmet needs in the animal and human health space. For example, the production of high-quality plasmid DNA for mRNA vaccine manufacturing, biologics such as enzymes or biotherapeutics, or administration of the novel organism as a standalone Living Therapeutic.